SEATTLE, WASHINGTON
February 13–16, 2017

 
Click the image above to visit the CROI 2017 site directly for full webcast and workshop information.

Selected Presentations from CROI 17

Simple risk score can identify gay men who may have acute HIV infection

Aidsmap | Mar 7, 2017

Brief Behavioral Intervention Increases PrEP Drug Levels in a Real World Setting

CROI, February 13-16, 2017, Seattle

Cancer Incidence Among Persons on Modern Suppressive Antiretroviral Therapy, 2000-12

CROI, February 13-16, 2017, Seattle

Incidence of Hepatitis C Among HIV-Infected Men Who Have Sex with Men in San Diego, 2000–2015

CROI 2017 Feb 14-16 Seattle, WA

Elsulfavirine as Compared to Efavirenz in Combination with TDF/FTC: 48-week Study

CROI 2017 Feb 14-16 Seattle, WA

Well-Treated HIV Is Still Associated With Vascular Abnormalities in the Brain

POZ | Feb 24, 2017

State-Level Estimates of HIV Incidence, Prevalence, and Undiagnosed Infections

CROI | February 13-16, 2017, Seattle

TLR7 Agonist Treatment of SIV+ Monkeys on ART Can Lead to Complete Viral Remission

CROI | February 13-16, 2017, Seattle

Novel Non-Catalytic Site Integrase Inhibitor with Improved Resistance Profile

CROI | February 13-16, 2017, Seattle

Nonlung Cancer Incidence Drops Quickly After Smoking Stops in HIV Group
CROI | February 13-16, 2017

Higher Rates of Heart Disease, Diabetes, Neuropathy in Older Men With vs Without HIV
CROI | February 13-16, 2017, Seattle

PrEP is NOT PERFECT - Transmission Occurs on PrEP
CROI | February 13-16, 2017, Seattle

Time spent with HIV viral load >1500 copies/mL among patients in HIV care, 2000–2014…..'viral suppression on HAART and early start is top federal priority'

CROI | February 13-16, 2017, Seattle

Only Half of Big US HIV Group Had Durable Viral Suppression in 2014
CROI | February 13-16, 2017

One in five 'heterosexual' men in the UK caught their HIV from another man

aidsmap | Feb 18, 2017
PEP With Doxycycline Halves Bacterial STI Rate in MSM on TDF/FTC PrEP
CROI | February 13-16, 2017
HIV More Than Doubles Odds of Cerebral Small-Vessel Disease in French Study
CROI | February 13-16, 2017
Infants treated within days of birth can clear HIV reservoir rapidly
aidsmap | Feb 15, 2017

New NNRTI doravirine shows good efficacy in phase 3 study

aidsmap | Feb 19, 2017
Frailty has a Stronger Association than Neurocognitive Impairment with Poor Outcomes
CROI | February 13-16, 2017
Monoclonal Antibody Suppresses HIV in Half With Multidrug-Resistant Virus
CROI | February 13-16, 2017
Less Inflammation Tied to Lower Frailty Progression, Greater Frailty Recovery
CROI | Feb 13-16, 2017
Monoclonal Antibody to IL-1beta Cuts Arterial Inflammation in 10 HIV Patients
CROI | Feb 13-16, 2017
HIV Infection and the Occurrence of Medically Significant Falls: Accelerated or Accentuated Aging?
CROI | Feb 13-16, 2017

"Critical Barrier" Between PrEP Interest and Uptake in Young Black MSM

CROI, February 13-16, 2017, Seattle

Bacterial Vaginosis Does Not Affect Oral TDF/FTC PrEP Efficacy

CROI, February 13-16, 2017, Seattle

Human Confirmation of Oral Dose Reduction Potential of Nanoparticle Antiretroviral Formulations

CROI 2017 Feb 14-16 Seattle, WA

High prevalence of hepatitis C virus among HIV negative MSM in the Amsterdam PrEP project

CROI 2017 Feb 14-16 Seattle, WA

Low Prevalence of HIV Drug Resistance with Modern Agents

CROI 2017 Feb 14-16 Seattle, WA

Cognitive Trajectories in Suppressed HIV Infection Indicate Evolving Disease Activity

CROI | February 13-16, 2017, Seattle

HIV Incidence, Prevalence and Undiagnosed Infections in Men Who Have Sex With Men

CROI | February 13-16, 2017, Seattle

WEBCAST: GS-9131 is a Novel NRTI with Activity Against NRTI-Resistant HIV-1

CROI | February 13-16, 2017, Seattle

CROI: GS-9131 is a Novel NRTI with Activity Against NRTI-Resistant HIV-1

NATAP | Feb 23, 2017

Longitudinal Assessment of Regionally Specific Brain Volumes in Treated HIV+ Patients

CROI | February 13-16, 2017, Seattle

Really Rapid Review -- CROI 2017, Seattle
TheBody | February 19, 2017

Incidence of Hepatitis C Among HIV-Infected Men Who Have Sex With Men, 2000-2015
CROI | February 13-16, 2017, Seattle
Antibiotic Prophylaxis for STIs: Promises or Perils
CROI | February 13-16, 2017
HIV Compartmentalization in Central Nervous System During Acute Infection
CROI | February 13-16, 2017
Cardiovascular Risk More Likely With Longer Viral Control in WIHS Women
CROI | February 13-16, 2017
Three in 30 Infants Treated in First 48 Hours of Life Become PCR Negative
CROI | February 1 3-16, 2017
New Integrase Inhibitor Attains 97% Viral Suppression Through 48 Weeks
CROI | February 13-16, 2 017
Higher Rates of Heart Disease, Diabetes, Neuropathy in Older Men With vs Without HIV
CROI | February 13-16, 2017
Steady Drop in Time Spent With Viral Load Above 1500 Copies in US Group
CROI | February 13-16, 2017
No HIV Evolution in CHER Children With Viral Control Through 7 Years of ART
CROI | Feb 13-16, 2017
Cardiovascular Risk as Great With Darunavir as With Indinavir or Lopinavir
CROI | Feb 13-16, 2017

Acute infection with a wild-type HIV-1 virus in a PrEP user with high TDF levels

CROI 2017 Feb 14-16 Seattle, WA